[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100542307":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":15,"locations":22,"responsibleParty":40,"collaborators":42,"id":49,"slug":50,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":55,"eligibilityCriteria":56,"healthyVolunteers":51,"sex":57,"minAge":58,"maxAge":10,"enrollmentInfo":59,"targetDuration":10,"studyType":62,"phases":10,"briefSummary":63,"conditions":64,"keywords":10,"overallStatus":24,"whyStopped":10,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":75},{"fullName":5,"class":6},"Centro Cardiologico Monzino","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Prospective Cohort",null,"Prospectively enrolled patients will undergo a complete assessment, as clinically indicated, including clinical evaluation, TTE, rest ECG, 24h ECG-monitoring, and CMR. CMR will be performed no more than 6 months apart from other examinations (TTE, rest ECG, 24h ECG-monitoring).",{"label":13,"type":10,"description":14,"interventionNames":10},"Retrospective Cohort","Patients will be enrolled retrospectively, in case they have already performed all examinations between 2016 and 2023",[16],{"name":17,"role":18,"phone":19,"phoneExt":20,"email":21},"Gianluca Pontone, MD","CONTACT","0258002574","+39","gianluca.pontone@cardiologicomonzino.it",[23],{"facility":5,"status":24,"city":25,"state":25,"zip":26,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"RECRUITING","Milan","20131","Italy","IT",{"type":30,"coordinates":31},"Point",[32,33],9.18951,45.46427,{"lat":33,"lon":32},[36],{"name":37,"role":18,"phone":38,"phoneExt":20,"email":39},"Chiara Centenaro","0258002031","chiara.centenaro@cardiologicomonzino.it",{"type":41,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[43,45,47],{"name":44,"class":6},"Humanitas Hospital, Italy",{"name":46,"class":6},"IRCCS Ospedale San Raffaele",{"name":48,"class":6},"Azienda Ulss 2 Marca Trevigiana","100542307","multiparametric-scores-for-prediction-of-myocardial-fibrosis-in-patients-with-mitral-valve-prolapse-100542307",false,"NCT06341166","Multiparametric SCores for Prediction of Myocardial fIbrosis in Patients With MITral vAlve pRolapse","Multiparametric SCores for Prediction of Myocardial fIbrosis in Patients With MITral vAlve pRolapse: the SCIMITAR Trial","SCIMITAR","Inclusion Criteria:\n\n* age ≥ 18 years\n* Echocardiographic diagnosis of mitral valve prolaspe, defined as a systolic displacement of one or both mitral leaflets ≥ 2 mm above the plane of the mitral valve annulus in long-axis views\n\nExclusion Criteria:\n\n* age\\\u003C 18 years\n* coexistence of other cardiomyopathies or other ≥ moderate valve diseases\n* scarce acoustic transthoracic echocardiographic window\n* usual contraindications for cardiac magnetic resonance","ALL","18 Years",{"count":60,"type":61},300,"ESTIMATED","OBSERVATIONAL","This is a multicenter, observational prospective and retrospective study which aims are: 1) to compute a scoring model potentially predictive for the diagnosis of fibrosis by CMR in patients with MVP; 2) to identify specific features that may predispose to ≥ mild VAs or SCD in patients with MVP.",[65],"Mitral Valve Prolapse","2026-01-30",{"date":68,"type":69},"2026-02-03","ACTUAL",{"date":71,"type":69},"2023-06-19",{"date":73,"type":61},"2026-06-19",{"name":5,"class":6},1]